ANAB vs RTX · rev $234.6M vs P/E 36, rev $46.78B
AnaptysBio Inc (ANAB) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
ANAB currently screens at market cap $1.62B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the ANAB and RTX stock pages for the full models.
Not investment advice.